The exact treatment for PE depends on its severity and whether you need critical treatment in an emergency room setting. PE medications are usually considered before medical procedures.
The trial adds much-needed randomized data to an area where it’s been lacking. Questions about methods muddy interpretation.
A nationwide retrospective study evaluated health care resource utilization and outcomes among patients with ...
KKR's acquisition of SunFireMatrix and Consello's purchase of EHE Health are among the deals that exemplify the new trends.
Julie Bulman, MD, presented the results of the pilot ENGULF trial. The two-phase, prospective, single-arm study assessed the ...
Penumbra (PEN) announced new data that demonstrate patients with intermediate-risk pulmonary embolism – PE – treated with ...
Findings from the first international randomized controlled trial to compare patient outcomes following treatment with ...
“These results are crucial to guiding optimal PE treatment decisions, providing strong evidence that FlowTriever may reduce clinical deterioration and the need for reintervention through more ...
(Nasdaq:NARI) today announced positive results from its prospective PEERLESS trial for the FlowTriever system.